APA Citatie

Steuer, C. E., & Ramalingam, S. S. (2020). EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): Ready for the clinic? Transl Lung Cancer Res.

Chicago Style citaat

Steuer, Conor E., en Suresh S. Ramalingam. "EGFR Tyrosine Kinase Inhibitors (TKIs) for Adjuvant Therapy of Early-stage Non-small Cell Lung Cancer (NSCLC): Ready for the Clinic?" Transl Lung Cancer Res 2020.

MLA citatie

Steuer, Conor E., en Suresh S. Ramalingam. "EGFR Tyrosine Kinase Inhibitors (TKIs) for Adjuvant Therapy of Early-stage Non-small Cell Lung Cancer (NSCLC): Ready for the Clinic?" Transl Lung Cancer Res 2020.